Food for Thought30 Apr 2021 15:22
As we all know Vela isn't a covid stock, far from it. But most of us know how well certain covid stocks have performed over the past year, and the one which sticks out for me is Novacyt
I don't know too much about NCYT as a company, but i do know that in September last year the share price went up by over 300% in a month on the release of their covid antibody test. Before this rise NCYT was already a £200m+ company, so for it to 3 bag for releasing a covid test is pretty impressive
Now of course both Vela and Novacyt are completely different companies when you compare their business structure, size, field of work, etc, so there are many things which cannot be compared between the two. But in regards to releasing a product into the current market, in Vela's case a potential covid TREATMENT, for a company currently valued at a mere £10m i think this could exceed many people's expectations if the AZD 1656 trial is a success